Literature DB >> 11144098

Inhaled nitric oxide ameliorates postoperative acute graft dysfunction after living-donor lobar lung transplantation.

T Yoshikawa1, H Date, M Yamashita, I Nagahiro, M Aoe, N Shimizu.   

Abstract

Inhaled nitric oxide, a selective pulmonary vasodilator, decreases mean pulmonary artery pressure and pulmonary vascular resistance and improves oxygenation in previously unobtainable ways without significant changes in systemic hemodynamics. We report successful treatment of a patient with acute graft dysfunction after living-donor lobar lung transplantation using nitric oxide inhalation.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11144098     DOI： 10.1007/BF03218245

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN： 1344-4964


  10 in total

Review 1.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 2.  Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Biochem Pharmacol       Date:  1989-06-01       Impact factor: 5.858

3.  Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation.

Authors:  S Rimar; C N Gillis
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

4.  [First successful bilateral living-donor lobar lung transplantation in Japan].

Authors:  N Shimizu; H Date; M Yamashita; M Aoe; I Nagahiro; T Yoshikawa; A Andou
Journal:  Nihon Geka Gakkai Zasshi       Date:  1999-12

5.  Living-donor lobar lung transplantation experience: intermediate results.

Authors:  V A Starnes; M L Barr; R G Cohen; J A Hagen; W J Wells; M V Horn; F A Schenkel
Journal:  J Thorac Cardiovasc Surg       Date:  1996-11       Impact factor: 5.209

6.  Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation.

Authors:  I Adatia; C Lillehei; J H Arnold; J E Thompson; R Palazzo; J C Fackler; D L Wessel
Journal:  Ann Thorac Surg       Date:  1994-05       Impact factor: 4.330

7.  Inhaled nitric oxide reduces human lung allograft dysfunction.

Authors:  H Date; A N Triantafillou; E P Trulock; M S Pohl; J D Cooper; G A Patterson
Journal:  J Thorac Cardiovasc Surg       Date:  1996-05       Impact factor: 5.209

8.  Inhaled nitric oxide for the adult respiratory distress syndrome.

Authors:  R Rossaint; K J Falke; F López; K Slama; U Pison; W M Zapol
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

9.  Lung transplantation. Analysis of thirty-six consecutive procedures performed over a twelve-month period. The Washington University Lung Transplant Group.

Authors:  D A Haydock; E P Trulock; L R Kaiser; N A Ettinger; A N Triantifillou; L L Ochoa; M K Pasque; S R Knight; J D Cooper
Journal:  J Thorac Cardiovasc Surg       Date:  1992-02       Impact factor: 5.209

10.  Inhalation of nitric oxide after lung transplantation.

Authors:  L Lindberg; T Sjöberg; R Ingemansson; S Steenb
Journal:  Ann Thorac Surg       Date:  1996-03       Impact factor: 4.330
  10 in total
  1 in total

Review 1.  Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review.

Authors:  Laura C Price; Stephen J Wort; Simon J Finney; Philip S Marino; Stephen J Brett
Journal:  Crit Care       Date:  2010-09-21       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.